Read + Share
Amedeo Smart
Independent Medical Education
Kulasekararaj AG, Risitano AM, Maciejewski JP, Notaro R, et al. Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab. Blood 2021;138:1928-1938.PMID: 34314483
Email
LinkedIn
Facebook
Twitter
Privacy Policy